ID   B1203L
AC   CVCL_8658
DR   CLO; CLO_0050057
DR   BioSample; SAMN03471929
DR   RCB; RCB2818
DR   Wikidata; Q54752326
RX   PubMed=11267941;
RX   PubMed=12114371;
RX   PubMed=16651449;
RX   PubMed=17131342;
RX   PubMed=17511773;
RX   PubMed=17725806;
RX   PubMed=19799608;
CC   Population: Japanese.
CC   HLA typing: A*24:02,24:02; B*52:01,54:01; C*12:02,01:02 (PubMed=12114371).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): RCB
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 9,10
ST   vWA: 18
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
RX   PubMed=11267941; DOI=10.1111/j.1349-7006.2001.tb01096.x;
RA   Takenoyama M., Yoshino I., Eifuku R., So T., Imahayashi S., Sugaya M.,
RA   Yasuda M., Inoue M., Ichiyoshi Y., Osaki T., Nagashima A., Nomoto K.,
RA   Yasumoto K.;
RT   "Successful induction of tumor-specific cytotoxic T lymphocytes from
RT   patients with non-small cell lung cancer using CD80-transfected
RT   autologous tumor cells.";
RL   Jpn. J. Cancer Res. 92:309-315(2001).
//
RX   PubMed=12114371; DOI=10.1378/chest.122.1.282;
RA   Sugaya M., Takenoyama M., Osaki T., Yasuda M., Nagashima A., Sugio K.,
RA   Yasumoto K.;
RT   "Establishment of 15 cancer cell lines from patients with lung cancer
RT   and the potential tools for immunotherapy.";
RL   Chest 122:282-288(2002).
//
RX   PubMed=16651449; DOI=10.1158/0008-5472.CAN-05-3840;
RA   Fukuyama T., Hanagiri T., Takenoyama M., Ichiki Y., Mizukami M.,
RA   So T., Sugaya M., So T., Sugio K., Yasumoto K.;
RT   "Identification of a new cancer/germline gene, KK-LC-1, encoding an
RT   antigen recognized by autologous CTL induced on human lung
RT   adenocarcinoma.";
RL   Cancer Res. 66:4922-4928(2006).
//
RX   PubMed=17131342; DOI=10.1002/ijc.22396;
RA   Sugaya M., Takenoyama M., Shigematsu Y., Baba T., Fukuyama T.,
RA   Nagata Y., Mizukami M., So T., Ichiki Y., Yasuda M., So T.,
RA   Hanagiri T., Sugio K., Yasumoto K.;
RT   "Identification of HLA-A24 restricted shared antigen recognized by
RT   autologous cytotoxic T lymphocytes from a patient with large cell
RT   carcinoma of the lung.";
RL   Int. J. Cancer 120:1055-1062(2007).
//
RX   PubMed=17511773; DOI=10.1111/j.1349-7006.2007.00507.x;
RA   Fukuyama T., Ichiki Y., Yamada S., Shigematsu Y., Baba T., Nagata Y.,
RA   Mizukami M., Sugaya M., Takenoyama M., Hanagiri T., Sugio K.,
RA   Yasumoto K.;
RT   "Cytokine production of lung cancer cell lines: correlation between
RT   their production and the inflammatory/immunological responses both in
RT   vivo and in vitro.";
RL   Cancer Sci. 98:1048-1054(2007).
//
RX   PubMed=17725806; DOI=10.1111/j.1349-7006.2007.00586.x;
RA   Baba T., Hanagiri T., Ichiki Y., Kuroda K., Shigematsu Y.,
RA   Mizukami M., Sugaya M., Takenoyama M., Sugio K., Yasumoto K.;
RT   "Lack and restoration of sensitivity of lung cancer cells to cellular
RT   attack with special reference to expression of human leukocyte
RT   antigen class I and/or major histocompatibility complex class I chain
RT   related molecules A/B.";
RL   Cancer Sci. 98:1795-1802(2007).
//
RX   PubMed=19799608; DOI=10.1111/j.1349-7006.2009.01351.x;
RA   Kuroda K., Takenoyama M., Baba T., Shigematsu Y., Shiota H.,
RA   Ichiki Y., Yasuda M., Uramoto H., Hanagiri T., Yasumoto K.;
RT   "Identification of ribosomal protein L19 as a novel tumor antigen
RT   recognized by autologous cytotoxic T lymphocytes in lung
RT   adenocarcinoma.";
RL   Cancer Sci. 101:46-53(2010).
//